The Effectiveness of Telerehabilitation in Stroke Patients

July 9, 2023 updated by: Fettah Saygılı, Gazi University

The Effectiveness of Modified-Constraint Induced Movement Therapy Based Telerehabilitation in Stroke Patients

Stroke, according to the definition of the World Health Organization (WHO); It is a syndrome characterized by a rapid settlement of signs and symptoms of focal loss of cerebral function without a cause other than vascular causes. As it is known, it is important for patients to regain functional skills in the upper extremities after stroke. Modified-Constraint Induced Movement Therapy (m-CIMT) is a versatile neurorehabilitation technique that aims to improve motor function in the hemiparetic upper extremity and increase its use in daily life activities. However, as in the Covid-19 pandemic, patients cannot always reach rehabilitation services. In such cases, telerehabilitation is a treatment option. There are a limited number of studies in which m-CIMT is applied according to the principle of telerehabilitation, which has become a necessity, especially due to the Covid-19 pandemic. Therefore, the aim of this study is to examine the effects of m-CIMT on upper extremity motor functions in stroke patients.

Study Overview

Status

Completed

Conditions

Detailed Description

This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Patients in both groups will be given lower-upper extremity exercises and gait training exercises selected according to the Bobath approach as a home program consisting of 10 exercises to be applied 5 days a week for 3 weeks. All patients will perform the same exercises. In addition, the exercise group will receive Modified-Constraint Induced Movement Therapy (m-CIMT) based telerehabilitation via video conferencing 5 days a week for 3 weeks. Patients in the m-CIMT group will be asked to restrict the movements of their less affected hands by using mitt for 5 hours a day/ 5 days a week for 3 weeks while the patients are awake. Evaluations for both groups will be made by a physiotherapist blinded to the study twice, at the beginning and 3 weeks later. As outcome measures functional performance, hand strength, activities of daily living and quality of life will be evaluated.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18-65 years of age
  • Being diagnosed with stroke for the first time by a doctor
  • Having been diagnosed with stroke at least 1 month ago
  • Mini-Mental Test Score more than or equal 24
  • In the upper extremities; Starting from the angle of full flexion, wrist extension of at least 20° or more, thumb extension or abduction of at least 10°, minimum extension of all other fingers at the metacarpophalangeal and interphalangeal joints
  • Having less than 2.5 points in the pre-treatment evaluation from both parts of MAG-28
  • Being able to stand for 2 minutes without any help by using the upper extremity as a support tool when necessary.
  • Absence of severe pain to affect the treatment
  • Absence of severe spasticity to affect the treatment (spasticity in any joint of the upper extremity ≤ 2 according to the Modified Ashworth Scale)

Exclusion Criteria:

  • Any orthopedic, vision, hearing or perception problems that may affect the research results
  • Having an additional neurological, cardiovascular, pulmonary or hormonal disorder that would prevent participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Group
The group will receive modified-Constraint Induced Movement Therapy via telerehabilitation and a home exercise program.
M-CIMT-based telerehabilitation will be implemented.
Lower and upper extremity exercises and gait training exercises selected according to the Bobath approach will be given as a home program consisting of 10 same exercises.
Active Comparator: Control group
The group only will be given a home exercise program.
Lower and upper extremity exercises and gait training exercises selected according to the Bobath approach will be given as a home program consisting of 10 same exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper extremity motor ability-Baseline
Time Frame: Assessment will be conducted before the intervention.
Wolf Motor Function Test
Assessment will be conducted before the intervention.
Upper extremity motor ability-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
Wolf Motor Function Test
Assessment will be conducted immediately after the intervention.
Upper extremity motor function-Baseline
Time Frame: Assessment will be conducted before the intervention.
The Fugl-Meyer Assessment of the Upper Extremity
Assessment will be conducted before the intervention.
Upper extremity motor function-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
The Fugl-Meyer Assessment of the Upper Extremity
Assessment will be conducted immediately after the intervention.
Activities of daily living related to the upper extremity-Baseline
Time Frame: Assessment will be conducted before the intervention.
Motor Activity Log-28 (MAL-28) The minimum score that can be obtained from this scale is 0, and the maximum score is 5. Higher scores mean that the level of use and quality of use is better.
Assessment will be conducted before the intervention.
Activities of daily living related to the upper extremity-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
Motor Activity Log-28 (MAL-28) The minimum score that can be obtained from this scale is 0, and the maximum score is 5. Higher scores mean that the level of use and quality of use is better.
Assessment will be conducted immediately after the intervention.
Voluntary movement and mobility-Baseline
Time Frame: Assessment will be conducted before the intervention.
Stroke Rehabilitation Assessment of Movement (STREAM)
Assessment will be conducted before the intervention.
Voluntary movement and mobility-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
Stroke Rehabilitation Assessment of Movement (STREAM)
Assessment will be conducted immediately after the intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric hand strength-Baseline
Time Frame: Assessment will be conducted before the intervention.
J-Tech™
Assessment will be conducted before the intervention.
Isometric hand strength-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
J-Tech™
Assessment will be conducted immediately after the intervention.
Isometric pinch strength-Baseline
Time Frame: Assessment will be conducted before the intervention.
Baseline® pinch meter
Assessment will be conducted before the intervention.
Isometric pinch strength-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
Baseline® pinch meter
Assessment will be conducted immediately after the intervention.
manual dexterity performance-Baseline
Time Frame: Assessment will be conducted before the intervention.
nine-hole peg test (9-HTP)
Assessment will be conducted before the intervention.
manual dexterity performance-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
nine-hole peg test (9-HTP)
Assessment will be conducted immediately after the intervention.
level of independence in activities of daily living-Baseline
Time Frame: Assessment will be conducted before the intervention.
Functional Independence Measure
Assessment will be conducted before the intervention.
level of independence in activities of daily living-Post intervention
Time Frame: Assessment will be conducted immediately after the intervention.
Functional Independence Measure
Assessment will be conducted immediately after the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Arzu Güçlü-Gündüz, PT, PhD., Professor
  • Study Chair: Fettah SAYGILI, PT, M.Sc., Research assistant

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2021

Primary Completion (Actual)

October 1, 2022

Study Completion (Actual)

October 20, 2022

Study Registration Dates

First Submitted

October 28, 2021

First Submitted That Met QC Criteria

November 9, 2021

First Posted (Actual)

November 22, 2021

Study Record Updates

Last Update Posted (Actual)

July 11, 2023

Last Update Submitted That Met QC Criteria

July 9, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make IPD data but when the statistical analysis of all data is made, all results will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Exercise

Subscribe